Early flu antiviral trial for adults with confirmed influenza
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign consent to join
- You’re age 18 to 60
- Your flu symptoms started within the last 4 days (96 hours)
- You test positive for flu (rapid test or PCR) within the past 24 hours
- You can walk by yourself without major help in daily activities
- You can return for follow-up visits and follow study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called Apomivir to see if it safely and effectively treats flu symptoms. It may help you recover faster if you have the flu.
This trial tests a new quadrivalent influenza (flu) vaccine in adults 18 and older. It aims to see if the vaccine is safe and helps protect against the flu. You may be able to join if you are generally healthy and have not had the flu or a flu shot recently.
This trial tests whether two flu medicines—baloxavir and oseltamivir—work better to treat influenza in people with weakened immune systems (like transplant or blood cancer patients). It may help reduce severe complications, especially when flu affects the lungs or is at high risk to do so.
This trial tests an oral tablet (SYH2085) to see if it can help adults with the flu feel better faster. If you join, you'll either get the study drug or a placebo (a pill with no medicine).
This study compares two versions of an antiviral medicine called Ingavirin to see how your body processes them and whether they are safe. Researchers will give you the medicine on an empty stomach and after eating to understand how food affects how your body absorbs it.
This study tests an investigational flu medicine (called Suraxavir Marboxil) for children with the flu. The goal is to see if it safely and effectively treats flu symptoms and shortens the illness.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.